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Introduction
Progress in nanotechnology has brought countless novel applications [1] in different areas such as material science, energy or health. In the latest, nanometre-scale chemical engineering is providing novel tools for diagnostics, therapeutics and sensoring [2] [3] .
One example is given by iron oxide nanoparticles (IONP), which are finding a rapidly increasing number of biomedical applications thanks to their suitable structural, colloidal, and magnetic properties [4] . Nowadays, IONP are employed as suitable platforms for biosensing [2] , biomolecular-magnetic trapping [5] , magnetic hyperthermia [6] , imaging [7] , drug-or gene-delivery [8] [9] . There is a wide variety of IONP preparation methods providing controllable nanoparticle size and customized physical, chemical and biological functionalities without cytotoxicity drawbacks [4, [10] [11] [12] [13] [14] . The coprecipitation of iron salts in water is the most widely used chemical method for synthesis of IONP [14] . Such chemical route provides crystalline IONP from the transformation of a mixture of ferric and ferrous salts in alkaline aqueous medium.
Appropriated chemical procedures [4, 15] The success of IONP on distinct biomedical applications requires to overcome safety concerns [16] [17] [18] . The assessment of IONP toxicity, biodistribution and excretion routes after long-term exposure is mandatory prior to a safe incorporation into clinical practice. Little attention has been paid to the effects related to IONP oral exposure in spite of the use of engineered nanoparticles for nutritional [19] [20] [21] [22] [23] and pharmaceutical [8, [24] [25] purposes is expected to increase [20, [26] [27] ]. An important issue is related to the oral administration of nanoparticles where magnetic ones offer the possibility to magnetically guide the drug delivery to intentionally enhance the drug release into the affected tissue [8] . There exist toxicity and gastro-intestinal functioning concerns related to the oral exposure to IONP, especially regarding the absorption of metals like iron [20, [28] [29] . Dietary iron is found in two basic forms [30] [31] , either as haemfound in meat-or non-haem iron -present in cereals, vegetables, beans, fruits, etc. in a number of forms ranging from simple iron oxides and salts to more complex organic chelates. Haem iron is more bioavailable than the non-haem form and their absorption takes place by different pathways. It is well accepted that the main iron absorption takes place in duodenum. In case of non-haem iron, there are two main transport mechanisms to enter into enterocytes. These mechanisms tightly depend on the iron oxidation state: ferrous (i.e. Fe(II)), or ferric (i.e. Fe(III)) forms. Thus, luminal Fe(II) absorption involves divalent metal transporter-1 (DMT1) whereas luminal Fe(III) is proposed to undergo enzymatic reduction to Fe(II), by duodenal cytochrome B (DcytB), prior to apical DMT1 transport from lumen into labile iron pool in the cytoplasm of the enterocytes. Recently, Simovich et al. [32] proposed a novel and different ferric pathway at the apical surface of the villus which is specific for the uptake of the ferric form without previous enzymatic reduction. Such iron transport process involves the participation of four proteins in two stages. Firstly, luminal Fe(III) is chelated by mucins, then ferrous iron crosses the membrane in association with β 3 -integrin and mobilferrin to internalize into cytosol. Secondly, this Fe(III) and protein complex combines with flavin monooxygenase and β 2 -microglobulin (β 2 -m) leading to paraferritin complex where Fe(III) is reduced to Fe(II). Once non-haem iron is inside the enterocyte, it can be either stored as ferritin or exported through the basolateral membrane from the ferrous iron pool to blood stream by the combined action of ferroportin (FPN) and hephaestin. [ [7] [8] .
Here, we report on the effects of chronic oral exposure to IONP in growing chickens.
Animal observation, diet intake and body weight reveal no adverse signs, symptoms, or mortality after 14 days of low dose IONP oral exposure. No IONP accumulation in liver, spleen and duodenum has been observed, while faeces appear as the main IONP excretion route. In addition, the liver iron level and the duodenal villi morphology reveal that iron from IONP is available. The analysis of haematological parameters indicates normality after chronic IONP dietary treatment. Duodenal gene expression studies on non-haem iron transport indicate that the ferrous pathway is inhibited whilst the ferric pathway is enhanced, supporting the involvement of mucins in iron solubility and transport into enterocytes.
Materials and methods

Synthesis of γ-Fe 2 O 3 nanoparticles
The synthesis of γ-Fe 2 O 3 nanoparticles coated with amino dextran (AD) was carried out in two steps procedure. In the first step, Fe 3 O 4 nanoparticles were synthesized following the co-precipitation protocol described by Massart et al. [14] and including some modification [39] of the reaction conditions allows to obtain γ-Fe 2 O 3 IONP of 12 nm size and narrow size distribution. In the second step, we proceed to modify the surface of nanoparticles. An aqueous solution of 500 mg of nanoparticles was dispersed in 70 mL of water at pH 11 (adjusted with KOH). AD (500 mg) was dissolved in 30 mL of water and added to nanoparticle dispersion very slowly and sonicated for twelve hours. The excess of coating was washed by dialysis against distilled water. Finally, the particles were dried on a stove to get the γ-Fe 2 O 3 IONP powder.
Structural characterization of γ-Fe 2 O 3 nanoparticles
Particle shape, size and size distribution were determined by Transmission Electron Microscopy (TEM) using the 200 KeV JEOL 2000 FXII microscope for routine TEM images and 200 KeV JEOL JEM 2100 for high resolution Transmission Electron Microscopy (HRTEM) images. For that purpose nanoparticles were prepared by placing a drop of a dilute nanoparticle suspension on a carbon-coated copper grid covered with a perforated carbon film and allowing the solvent to evaporate slowly at room temperature. The nanoparticle size is 12 ± 2 nm. The average particle size and distribution were evaluated by measuring the largest internal dimension of 350 particles for the sake of statistical validity. The different size populations are organized into a histogram and are adjusted to a log-normal function. The particle surface coating was characterized by Fourier transform infrared spectra, recorded between 4000 and 300 cm-1 in a Bruker IFS 66 V-S spectrometer. Samples were prepared for infrared 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 characterization by diluting the iron oxide nanoparticle powder in KBr at 2% by weight and compressing the mixture, pressing it into a pellet. On the other hand, quantification of the coating was carried out by simultaneous thermogravimetric analysis and differential thermal analysis performed on a Seiko TG/DTA 320U thermobalance by heating particle dispersion from room temperature to 900 °C at 10 °C/ min under an air flow of 100 ml/ min. 
Magnetic characterization of iron oxide nanoparticles
Diet formulations
Three experimental diets were designed for the experiment. supernatants were removed and stored at -20°C until assayed. Liver and spleen: samples were washed with saline solution, weighted and frozen at -20º C until lyophilisation. For iron quantification, samples of liver and spleen tissues from 2 birds belonging to same diet were pooled and mashed (6 replicates per diet, 2 birds per replicate). For AC magnetic susceptibility measurements, pooled samples of liver and spleen tissues were prepared from mashed tissues out of 6 replicates with 2 birds per replicate. Duodenum: samples from 7 birds per diet were taken and washed with saline solution and divided into 3 different fragments. The first portion of duodenum intestinal mucosa was cleaned with saline solution before preserving in a clean microcentrifugetube (1.5 ml) and stored at -80ºC after freezing in liquid nitrogen for posterior gene expression study. The second duodenum portion was directly placed in 10% formalin 0.1 phosphate buffer (pH = 7) for subsequent histological studies. The third duodenal portion was frozen at -20ºC until lyophilisation for iron quantification.
Duodenal morphological studies
Samples were processed for 24 h in a tissue processor with ethanol and were embedded in paraffin. Sections (5 µm) were prepared from duodenal tissue and were stained with hematoxylin-eosin. Histological sections were examined with an an Olimpus optical microscope (Olimpus Optical Co., GmbH, Hamburg,Germany). The images were analyzed using an image software (Soft Imaging System, Olimpus, Hamburg, Germany). The variables measured were villus height, and crypt depth. A total of 10 intact, well-oriented villus-crypt units selected for each intestinal cross-section (6 cross-sections/sample). Villus height (µm) was measured from the tip of the villus to the villus-crypt junction, and crypt depth was defined as the depth of the invagination between adjacent villi. The average of these values was used for statistical analysis. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Cage pooled faeces, liver, spleen and duodenum tissues were lyophilised and mashed prior to acid digestion. Samples were incubated with 65% nitric acid (1 ml, 1 h, 60°C) for total iron quantification analysis determined per gram of tissue. Quantitative determination of iron was analysed by Inductively Coupled Plasma Atomic Emission Spectroscopy (Perkin Elmer OPTIMA 2100 DV).
Iron quantification in faeces, tissues and diets
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Solubility studies
The solubility tests was done according to the standardized method of Swain et al. 
Total RNA Extraction from duodenum tissues
Total RNA was extracted from seven duodenal tissue samples per diet by using RNeasy Mini Kit (Qiagen, Valencia, CA) and following the manufacturer's instruction, (Animal Tissues and Cells, DNase Digest). The extracted RNA mass values ranges from 4 to 29 mg. An automated RNA extraction system (QIAcube system, Qiagen) was used, in order to get the highest reproducibility. Total RNA was finally dissolved in 30 µL elution buffer and stored at -80° C. The quantity and quality of total RNA
were assessed on a NanoDrop-ND 1000 (Thermo Fisher Scientific Inc., Boston, MA)
and an Agilent 2100 Bioanalyzer, respectively. An aliquot of total RNA (1 µL) was analyzed in an Agilent 2100 Bioanalyzer (Agilent Technologies, Inc., Santa Clara, CA) using appropriated RNA Chips and reagents. The RNA integrity number (RIN) value is an empirical measure of RNA integrity based on the intensities of 28s and 18s rRNA 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 bands. The RIN value is based on an algorithm that assesses a number of features derived from an electropherogram profile for a given sample.
DMT1, DcytB, FPN and β2-m Gene Expression Analysis
cDNA was produced using the GoTaq Two
Step RT-PCR System A6010 (Promega, The number of cycles is referred to as the quantification cycle (Cq) value. The level of mRNA was normalized to 18S rRNA expression in each sample and presented as the ∆C q value (∆C q = C q target mRNA-C q 18S rRNA) [45] . Real Time PCR analysis of ∆C q for each sample was performed in triplicate, the average of these three values was used for statistical analysis.
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Statistical analysis
Data from the animal assays were subjected to a one-way analysis of variance by using the general linear model procedure (version 9.2, SAS Institute Inc., Cary, NC). Data are shown as mean values ± standard error of the mean (s.e.m). When the effect was declared significant (P<0.05), means were compared using a Tukey's Studentised range test.
Results and Discussions
Iron oxide nanoparticles
Single-phase γ- tissues. The AC magnetic susceptibility has two components: the in-phase susceptibility (χ') and the out-of-phase susceptibility (χ''). The out-of-phase component χ''(T) is only sensitive to mineralised iron, as the one forming the AD coated IONP, while the in-phase component χ'(T) includes the contribution from both mineralised iron, paramagnetic iron or other diamagnetic contributions [47] . Figure 2b shows the temperature dependence of χ''of the AD coated IONP powder. Briefly, the temperature behaviour of χ''(T) shows a maximum at around 220 K accompanied by a small shoulder at around 40 K. The maximum observed around 220 K is related to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 magnetic relaxation processes, while the feature observed at 40 K could be related to an uncoherent reversal of the magnetic moments of single domain non-interacting particles [48] . The overall thermal behaviour of χ''(T) can be used as an IONP fingerprint for tracking its presence in animal tissues or faeces after 14 days of oral exposure.
Birds and diets
Growing 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Figure 4 . The fact that liver and spleen weights are not influenced by diets implies that no toxicological signs such as inflammation were manifested in the animal growth of birds fed on IONP supplemented diet after 14 days.
IONP biodistribution and excretion
The IONP organ biodistribution analysis after chronic oral exposure was carried out on liver and spleen of birds fed on different diets. Several IONP biodistribution studies in animal models showed preferential accumulation in spleen and liver after intravenous injections, and to a lesser extent in other organs, depending on dosage [49] , surface coating [49] [50] or intravenous administration methodology [51] . The total IONP intake (58 mg) per bird along the dietary treatment period represents a relevant amount of magnetic nanomaterial for testing their safety since its accumulation in duodenum, spleen and liver can be tracked by AC magnetic measurements. Nonetheless, no signs of IONP accumulation in liver and spleen were observed for birds fed on γ-Fe 2 O 3 IONP supplemented diet as shown in Figure 5 . These results prove that after IONP oral exposure during 14 days, the accumulated IONP amounts in liver or spleen are insignificant or under the detection limit of AC magnetic susceptibility measurements.
IONP do not achieve blood stream from the gastrointestinal tract spite birds were fed ad libitum during 14 days. However, faecal AC magnetic data from birds fed on IONP supplemented diet show a χ''(T) profile (see Figure 5c ) which highly resembles the IONP powder data shown in Figure 2b . The slightly different temperature location of the χ''(T) maximum, in comparison with the IONP powder could be probably related to either a different IONP aggregation degree [49] , partial degradation of IONP, or both. In any case, excretion results reveal that IONP are highly ejected along the gastrointestinal tract.
Influence of dietary IONP treatment on iron storage
The different iron sources employed in diets may result in distinct iron solubility leading to different iron storage and transport pathways. Acid gastric conditions [43] and digestive transit times[42] of twenty-one-days-old Broiler chickens were simulated by in vitro acid digestions in order to detect and quantify by analytical means the release of iron atoms from IONP during their degradation. Table 1 shows the results of the iron solubility [52] from IONP under the different pH and acidic digestion times, mimicking gastric digestion conditions. The degradation of γ-Fe 2 O 3 nanoparticle releases ferric iron. Solubility values shown in Table 1 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 IONP supplemented diets but these values are significantly lower than for birds fed on ferrous sulphate supplemented diet (see Figure 6d) . Such similarities for non-iron and γ- Haematological parameters have been also analysed since they are expected to be sensitive to iron storage [54] . We have observed no influence of diets on the number of red blood cells, and haematocrit, haemoglobin and serum iron concentrations and their correspondence to bird age (see Tables S1 and S2 in Supporting Information).
Similarly, the serum proteinogram does not reflect differences between diets. Hence, haematological data reveal normality after 14 days of oral exposure to IONP as expected for a low dose (i.e. <24 mg/kg)[37]. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 is 100 times lower than γ-Fe 2 O 3 IONP and its observation requires animals with iron overload [57] [58] , what is not the case in our study. Thus, the higher villi development observed for birds fed on iron supplemented diets (independently on the iron source) than the non-iron supplemented-one underlines the iron bioavailability from ingested IONP. Recent studies [22] [23] 35] show that iron absorption from nanosize structures is favoured in comparison to microsize or bulk courterparts. Furthermore, authors suggest that the luminal non-haem iron released from nanostructures would imply ferrous absorption pathways (i.e. DMT1 and DcytB proteins) without showing experimental evidences.
Dietary IONP effects on duodenal morphology
Dietary IONP effects on duodenal gene expression
Iron absorption mechanisms are known to depend on iron forms. As mentioned above, it is well accepted the high bioavailability of Fe (II) from iron sulphate [35] and its absorption mechanism involving Dcytb-DMT1 proteins [30] . Figure 8 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 instead of ferrous-ones [32] . This may explain our experimental findings on Fe(III)
released from the partial transformation of crystalline γ-Fe 2 O 3 nanoparticles under acid gastric conditions. Fe(III) is susceptible to bind mucins [59] favoured by the low solubility of the ferric form into the intestinal mucosa resulting in bioavailable iron.
Conclusions
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